Study of a JAK3 Inhibitor for the Prevention of Acute Rejection in Kidney Transplant Patients

Clinical trial NCT00483756 · COMPLETED

Trial details

NCT number: NCT00483756
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Kidney Transplantation

Start date: 2007-08-01
Primary completion: 2010-02-01
Enrollment: 338

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.